These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 9674632)

  • 41. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
    Napoli C; Sica V; de Nigris F; Pignalosa O; Condorelli M; Ignarro LJ; Liguori A
    Am Heart J; 2004 Jul; 148(1):e5. PubMed ID: 15215814
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A double blind comparison of the effects of amlodipine and enalapril on insulin sensitivity in hypertensive patients.
    Lender D; Arauz-Pacheco C; Breen L; Mora-Mora P; Ramirez LC; Raskin P
    Am J Hypertens; 1999 Mar; 12(3):298-303. PubMed ID: 10192233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renin-Angiotensin System Blockade Associated with Statin Improves Endothelial Function in Diabetics.
    Gismondi RA; Bedirian R; Pozzobon CR; Ladeira MC; Oigman W; Neves MF
    Arq Bras Cardiol; 2015 Dec; 105(6):597-605. PubMed ID: 26465872
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.
    Giugliano D; Marfella R; Acampora R; Giunta R; Coppola L; D'Onofrio F
    Diabetes Care; 1998 Apr; 21(4):631-6. PubMed ID: 9571355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients.
    Schiffrin EL; Pu Q; Park JB
    Am J Hypertens; 2002 Feb; 15(2 Pt 1):105-10. PubMed ID: 11863244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal and vascular protective effects of telmisartan in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Sawada K
    Hypertens Res; 2006 Aug; 29(8):567-72. PubMed ID: 17137211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.
    Grimm RH; Flack JM; Grandits GA; Elmer PJ; Neaton JD; Cutler JA; Lewis C; McDonald R; Schoenberger J; Stamler J
    JAMA; 1996 May 22-29; 275(20):1549-56. PubMed ID: 8622245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study].
    Fan CM; Yan LR; Tao YK; Wang L; Li YQ; Gao MM; Wang YN; Li CX; Wang XW; Lu XL; Pang HM; Li YS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):57-60. PubMed ID: 21418799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus.
    Ritt M; Ott C; Raff U; Schneider MP; Schuster I; Hilgers KF; Schlaich MP; Schmieder RE
    Am J Kidney Dis; 2009 Feb; 53(2):281-9. PubMed ID: 19100670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential effects of antihypertensive drug therapy on arterial compliance.
    Resnick LM; Lester MH
    Am J Hypertens; 2002 Dec; 15(12):1096-100. PubMed ID: 12460707
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protection of the cardiovascular system by imidapril, a versatile angiotensin-converting enzyme inhibitor.
    Hosoya K; Ishimitsu T
    Cardiovasc Drug Rev; 2002; 20(2):93-110. PubMed ID: 12177688
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment with hypotensive agents affects the impaired relaxation of the penile corpus cavernosum in hypertensive rats.
    Ushiyama M; Kuramochi T; Katayama S
    Hypertens Res; 2006 Jul; 29(7):523-32. PubMed ID: 17044665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravenous administration of L-arginine inhibits angiotensin-converting enzyme in humans.
    Higashi Y; Oshima T; Ono N; Hiraga H; Yoshimura M; Watanabe M; Matsuura H; Kambe M; Kajiyama G
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2198-202. PubMed ID: 7608279
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes.
    Redon J; Pichler G;
    J Hypertens; 2016 Feb; 34(2):359-67. PubMed ID: 26867060
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renal nitric oxide and angiotensin II interaction in renovascular hypertension.
    Sigmon DH; Beierwaltes WH
    Hypertension; 1993 Aug; 22(2):237-42. PubMed ID: 8340159
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of lisinopril, irbesartan, and amlodipine on the thrombogenic variables in the early and late stages of the treatment in hypertensive patients.
    Tiryaki O; Usalan C; Buyukhatipoglu H; Sayiner ZA; Kilisli H
    Clin Exp Hypertens; 2012; 34(2):145-52. PubMed ID: 21967026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat.
    Nawano M; Anai M; Funaki M; Kobayashi H; Kanda A; Fukushima Y; Inukai K; Ogihara T; Sakoda H; Onishi Y; Kikuchi M; Yazaki Y; Oka Y; Asano T
    Metabolism; 1999 Oct; 48(10):1248-55. PubMed ID: 10535386
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cough-challenge trial with a new angiotensin-converting enzyme inhibitor, imidapril.
    Shionoiri H; Takasaki I; Minamisawa K; Ueda S; Kihara M; Shindo K; Hiroto S; Sugimoto K; Himeno H; Naruse M; Nagamochi I; Yasuda G
    J Clin Pharmacol; 1998 May; 38(5):442-6. PubMed ID: 9602958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.